Results 131 to 140 of about 1,394,911 (165)

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study. [PDF]

Ann Med
Lin X, Yang C, Liu Z, Zhuang J, Chen M, Han B.   +5 more
europepmc   +1 more source

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report. [PDF]

BMJ Open
Huang X, Liao X, Huang Y, Zhang C, Wang Z, Yu L.   +5 more
europepmc   +1 more source

Bridging the gaps between randomized controlled trials and real-world use of thrombopoietin receptor agonists for adult primary immune thrombocytopenia: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Luo L, Jin S, Song Z, Chong G, Ding H, Zeng S, Dai M, Wu M.   +7 more
europepmc   +1 more source

A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists. [PDF]

Front Nutr
Yassin MA, AlRasheed M, Al-Eisa T, Alhashim N, Alsayegh F, Abouzeid TE, Abd El Fattah M, Alfili M, Shalaby N, Alotaibi A, Aljuwaisri N, Almasbahi A, Saleeb R, Abdelaziz H, Alshurafa A, Ismail O, Ghasoub R.   +16 more
europepmc   +1 more source

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience.

Blood, 2022
Fattizzo B, Cecchi N, Bortolotti M, Giordano G, Patriarca A, Glenthøj A, Cantoni S, Capecchi M, Chen F, Mingot-Castellano ME, Napolitano M, Frederiksen H, Gonzaléz-Lopez TJ, Barcellini W.   +13 more
europepmc   +1 more source

[The application of thrombopoietin receptor agonists in the treatment of non-muscle myosin heavy chain 9-related disease]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Gong Y, Chen WL, Hu YJ, Mei H, Wang YD.
europepmc   +1 more source

Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists. [PDF]

Blood Rev
Al-Samkari H.
europepmc   +1 more source